Swedish ISR Inks MOU with Bangladesh CRO & Manufacturer to Develop Inhaled Vaccine Targeting COVD-19

Swedish ISR Inks MOU with Bangladesh CRO & Manufacturer to Develop Inhaled Vaccine Targeting COVD-19

A Swedish biotech firm called ISR Immune System Regulation Holding AB (“ISR”), which licensed the intellectual property for an inhalation vaccine against COVID-19 from Karolinska Institute, recently announced they inked a memorandum of understanding (MOU) to commence a vaccine study in Bangladesh this month. Actually, the Swedes were busy signing the MOU with Bangladesh Clinical Trials Ltd, which will serve as a local contract research organization (CRO), and with a pharmaceutical company to produce the vaccine in Bangladesh. Now paperwork must be filed with the Bangladesh Medical Research Council in order to proceed. Should regulators in that Asian nation authorize, then a principal of Mugda Medical College (Dr. Ahmedul Kabir) and a former dean of the medicine faculty at Bangabandhu Sheikh Mujib Medical University (Dr. ABM Abdullah) will serve as principal investigators. Presently, Bangladeshi press reports the two co-principal investors are drawing up the clinical trial’s protocol.

The Opportunity

The Swedish and Bangladeshi press recently reported growing challenges with COVID-19 vaccines, including breakthrough infections, waning effectiveness given n...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee